MPPLM
VRTX icon

Midwest Professional Planners Ltd (MPPL)’s Vertex Pharmaceuticals VRTX Stock Holding History

Midwest Professional Planners Ltd (MPPL)’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.58M Buy
3,549
+25
+0.7% +$11.7K 0.37% 81
2025
Q4 		$1.6M Buy
3,524
+28
+0.8% +$12.1K 0.38% 82
2025
Q3 		$1.37M Buy
3,496
+71
+2% +$29.7K 0.33% 83
2025
Q2 		$1.52M Sell
3,425
-30
-0.9% -$13.8K 0.4% 73
2025
Q1 		$1.68M Sell
3,455
-390
-10% -$182K 0.52% 62
2024
Q4 		$1.55M Buy
3,845
+255
+7% +$118K 0.46% 68
2024
Q3 		$1.67M Buy
3,590
+319
+10% +$153K 0.51% 62
2024
Q2 		$1.53M Buy
3,271
+212
+7% +$92K 0.51% 55
2024
Q1 		$1.28M Buy
3,059
+357
+13% +$151K 0.45% 68
2023
Q4 		$1.1M Buy
2,702
+172
+7% +$63.5K 0.44% 64
2023
Q3 		$880K Buy
2,530
+426
+20% +$149K 0.4% 64
2023
Q2 		$740K Buy
2,104
+446
+27% +$150K 0.32% 78
2023
Q1 		$522K Buy
1,658
+192
+13% +$57.6K 0.26% 84
2022
Q4 		$423K Buy
1,466
+264
+22% +$80.5K 0.23% 87
2022
Q3 		$348K Buy
1,202
+104
+9% +$29.9K 0.21% 91
2022
Q2 		$309K Buy
1,098
+146
+15% +$39.1K 0.17% 94
2022
Q1 		$248K Buy
+952
New +$226K 0.12% 108

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Midwest Professional Planners Ltd (MPPL)'s VRTX Position: Q1 2026 in Review

Midwest Professional Planners Ltd (MPPL) increased its Vertex Pharmaceuticals (VRTX) stake by 0.71% in Q1 2026, buying an estimated $11.7K and bringing the position to 3,549 shares worth $1.58M. The position accounts for 0.37% of the portfolio, ranked #81.

Midwest Professional Planners Ltd (MPPL) first reported a position in VRTX in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.68M in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Midwest Professional Planners Ltd (MPPL) held 3,549 shares of Vertex Pharmaceuticals worth $1.58M as of Q1 2026.
  • Midwest Professional Planners Ltd (MPPL) bought 25 Vertex Pharmaceuticals shares in Q1 2026, an estimated $11.7K.
  • Vertex Pharmaceuticals made up 0.37% of Midwest Professional Planners Ltd (MPPL)'s portfolio in Q1 2026, its #81 holding.
  • Midwest Professional Planners Ltd (MPPL) first reported a position in Vertex Pharmaceuticals in Q1 2022 and has held it in 17 quarters since.
  • Midwest Professional Planners Ltd (MPPL)'s Vertex Pharmaceuticals position peaked at $1.68M in Q1 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Midwest Professional Planners Ltd (MPPL)'s 13F filing for Q1 2026, filed 5 May 2026.